Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2023
Reply to E. Hindié
Hannah D McManus, Andrew J Armstrong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2023
The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer
Hannah D McManus, Andrew J Armstrong
Case Reports in Oncology
|
December 1, 2025
High-Risk Prostate Cancer in a Patient with Untreated Prolactinoma and Castrate-Level Testosterone Suppression: A Case Report
Tara A Seibert, Afreen Shariff, Hannah D McManus
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 20, 2026
Real-World Representation in Prostate Cancer Clinical Trials: Needs and Opportunities
Hannah D McManus, Daniel J George, Jeffrey W Shevach
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 12, 2025
Reducing unnecessary blood cultures in oncology through algorithmic stewardship in a tertiary medical center
María I Font Mera, Cameron Oswalt, Hannah D McManus, et al.
Prostate Cancer and Prostatic Diseases
|
October 17, 2024
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Hannah D McManus, Tanya Dorff, Alicia K Morgans, et al.
Urologic Oncology
|
April 4, 2026
Outcomes of Consolidative Surgery Following Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A Real-World Experience
Alireza Ghoreifi, Christopher J Hoimes, Sundhar Ramalingam, et al.
Clinical Genitourinary Cancer
|
April 5, 2025
Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma
Hannah D McManus, Jessica B Long, Sarah J Westvold, et al.
Clinical Genitourinary Cancer
|
June 4, 2023
Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab
Hannah D McManus, Dylan Zhang, Fides R Schwartz, et al.
JNCI Cancer Spectrum
|
May 18, 2023
Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma
Ryan D Chow, Jessica B Long, Sirad Hassan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2023
Reply to E. Hindié
Hannah D McManus, Andrew J Armstrong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2023
The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer
Hannah D McManus, Andrew J Armstrong
Case Reports in Oncology
|
December 1, 2025
High-Risk Prostate Cancer in a Patient with Untreated Prolactinoma and Castrate-Level Testosterone Suppression: A Case Report
Tara A Seibert, Afreen Shariff, Hannah D McManus
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 20, 2026
Real-World Representation in Prostate Cancer Clinical Trials: Needs and Opportunities
Hannah D McManus, Daniel J George, Jeffrey W Shevach
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 12, 2025
Reducing unnecessary blood cultures in oncology through algorithmic stewardship in a tertiary medical center
María I Font Mera, Cameron Oswalt, Hannah D McManus, et al.
Prostate Cancer and Prostatic Diseases
|
October 17, 2024
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey
Hannah D McManus, Tanya Dorff, Alicia K Morgans, et al.
Urologic Oncology
|
April 4, 2026
Outcomes of Consolidative Surgery Following Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A Real-World Experience
Alireza Ghoreifi, Christopher J Hoimes, Sundhar Ramalingam, et al.
Clinical Genitourinary Cancer
|
April 5, 2025
Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma
Hannah D McManus, Jessica B Long, Sarah J Westvold, et al.
Clinical Genitourinary Cancer
|
June 4, 2023
Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab
Hannah D McManus, Dylan Zhang, Fides R Schwartz, et al.
JNCI Cancer Spectrum
|
May 18, 2023
Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma
Ryan D Chow, Jessica B Long, Sirad Hassan, et al.
Page
of 2